As we had previously observed in the OVCAR3 cells, and consistent with the TCGA data set, our two cisplatin-resistant patient-derived tumor cells (OV no. 2224 and OV no. 3971) revealed RIPK3 protein expression upon immunoblot analysis (Figure 6b). The gene discussed is RIPK3; the disease is neoplasm.